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Abstract
Background: Achilles tendinopathy (AT) is a common overuse injury in running-related sports where patients
experience pain and impaired function which can persist. A graded rehabilitation program has been successful in
reducing pain and improving function to enable a return to sport. The aim of this study is to compare the
effectiveness of a criteria-based rehabilitation program including strength and reactive strength targets, with a
previously successful rehabilitation program on changes in pain and function using the Victorian Institute of Sport
Assessment-Achilles (VISA-A) questionnaire. Secondary aims will be to assess changes in calf strength, reactive
strength, and lower limb running and forward hop biomechanics over the course of a 12-week rehabilitation
program, and long-term follow-up investigations.
Methods: Sixty eligible participants with chronic mid-portion AT who train in running-based sports will be included
in this study. They will be randomly assigned to a group that will follow an evidence-based rehabilitation program
of daily exercises with progression guided by symptoms or a group performing 3 high-intensity rehabilitation
sessions per week with individualised load targets progressing to reactive strength exercises. Testing will take place
at baseline, week 6 and 12. Plantar flexor peak torque will be measured using isokinetic dynamometry, reactive
strength will be measured using a drop jump and lower limb biomechanical variables will be measured during a
single leg forward hurdle hop test and treadmill running using 3D motion analysis. Follow-up interviews will take
place at 6, 12 and 24 months after beginning the program which will assess patient participation in sport and
possible re-injury.
Discussion: This is the first study to propose an individualised criteria-based graded rehabilitation program in
patients in with chronic mid-portion Achilles tendinopathy where progression is guided by strength and reactive
strength outcome measures. This study will provide a comprehensive assessment of plantar flexor strength, reactive
strength and lower limb biomechanical variables in running and forward hopping with the VISA-A questionnaire as
the primary outcome measure and long term post-intervention follow-up assessments performed.
Trial registration: ClinicalTrials.gov (ID: NCT04384874). Registered retrospectively on April 23rd 2020.
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Background
The Achilles tendon is the largest and strongest tendon
in the human body [1] and usually withstands very high
tensile forces during exercise [2], but is also one of the
most commonly injured tendons [3]. Achilles tendinopa-
thy (AT) affects 2% of the general population [4], and
has an incidence of 7–9% in running-based sports with a
cumulative lifetime incidence of up to 52% among cer-
tain athletic populations [5].
Tendinopathy is described as pain and impaired
function in the affected tendon [6–8]. Over time this
may result in reduced physical activity, absenteeism
from sport and impaired quality of life [8]. Histologi-
cally and biochemically pathological tendon has been
shown to include increased hyper-cellularity, reduced
collagen type I and increased type III content, in-
creased proteoglycans and glycosaminoglycans, and
blood vessel in-growth [9, 10]. Excessive loading of
the tendon is believed to be the primary contributory
factor to Achilles tendinopathy [11]. The fibroblastic
cells known as tenocytes within the extracellular
matrix are sensitive to mechanical loading and, when
the tendon is overloaded, the cells alter the protein
composition of the matrix resulting in pathology and
reduced capacity for exercise [12].
Patients with AT usually present with pain, swelling
and impaired performance of the tendon [13], as well as
altered function of the plantar flexor muscles [14–16].
In a sporting population, training load perturbations
such as a rapid increase in training volume, intensity or
frequency are said to be common contributory factors
[17]. Re-injury rates are high, most likely due to incom-
plete restoration of muscle-tendon unit function [18],
and symptoms can persist for a number of years in some
cases [19]. In an eight-year follow-up study, 20% of pa-
tients still experienced impaired physical activity [20]. A
failed healing response and degenerative changes are as-
sociated with the development of chronic tendinopathy
resulting in reduced load capacity and persistent pain
symptoms [8]. This is described by Cook et al. [8] in
their proposed continuum model involving three stages:
reactive tendinopathy, tendon disrepair and degenerative
tendinopathy.
Impairments in tendon mechanical properties such as
stiffness and Young’s modulus have been highlighted in
AT [21–23]. Wang et al. (2012) observed reduced stiff-
ness and increased hysteresis of the Achilles tendon,
along with reduced rate of force development of the
plantar flexor muscles and reduced single leg horizontal
hop performance in symptomatic limbs of patients with
AT, compared to the non-symptomatic limb. While one
study found reduced lower limb stiffness in the injured
limb of runners with AT during hopping [24], biomech-
anical variables such as leg and joint stiffness in running
and hopping tasks have not been extensively researched
in patients with Achilles tendinopathy.
Many passive treatment therapies such as injections
[25, 26], Non-Steroidal Anti-Inflammatory Drugs (NSAI
Ds) [10, 27], ultrasound [10, 27], shockwave [28, 29],
laser [27], iontophoresis [25], acupuncture [30], orthotics
[25, 29], wearing a night splint [31], vibration and cryo-
therapy [32], mucopolysaccharides [33], and a wait-and-
see approach [28] have been used in the management of
AT. However, there is strongest evidence for the use of
exercise therapy as the primary treatment option [34–
36]. Tendons adapt to exercise as the mechanical per-
turbation of the inter- and intra-fascicular cells triggers
a molecular response signalling an expression of import-
ant proteins in the extra-cellular matrix which restore
the mechanical properties of the tendon [37, 38]. Three
main modes of exercise have been widely used, each as-
sociated with improvements in clinical symptoms to
varying degrees, namely: Alfredson’s eccentric protocol
[39], Silbernagel’s combined concentric-eccentric proto-
col [36] and the Heavy Slow Resistance protocol [40].
The Silbernagel protocol [see Table 1] comprises a com-
bined concentric-eccentric exercise program performed
daily, before progressing to plyometric exercises as
symptoms permit, with no individualisation of exercise
prescription and progression guided solely by pain
symptoms on a numeric pain rating scale (NPRS).
Recent evidence suggests that magnitude of loading,
irrespective of contraction mode, is the primary stimulus
for tendon adaptation [41]. Isometric exercises using 5 ×
45 s contractions at 70% maximal voluntary contraction
(MVC) have been used for early management of tendi-
nopathies with evidence suggesting an analgesic effect
[42]. However, this has been since contested by the find-
ings of O’Neill et al. [43]. Documented timeframes for
rehabilitation interventions vary between 6 weeks to sev-
eral months with no clear objective measures for return
to sport. Patients with AT display impaired reactive
strength qualities during hopping tasks and it is recom-
mended to include plyometric training at an advanced
stage of a rehabilitation program to prepare for the
stretch-shortening cycle demands of running-based
sports [19, 36]. A multi-stage rehabilitation program that
includes the combination of strength development and
plyometric training may thus be beneficial, but there is a
lack of consensus on assessing these qualities to guide
exercise prescription and progression through the re-
habilitation pathway.
While numerous studies have shown positive clinical
improvements and tendon adaptations to exercise [36,
39–41, 44], studies which investigate a periodised return
to sport rehabilitation program with load targets and
outcome measures for progression, are necessary due to
the individualised nature of its initial presentation and
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Table 1 Silbernagel’s combined concentric-eccentric program
Phase 1: Weeks 1–2
Patient status: Pain and difficulty with all activities, difficulty performing 10 single leg heel raises
Goal: Start to exercise, gain understanding of their injury and of pain monitoring model
Treatment program: Perform exercises every day:
• Pain monitoring model information and advice on exercise activity
• Circulation exercises (moving foot up and down)
• Double leg heel raises standing on the floor (3 × 10–15 repetitions)
• Single leg heel raises standing on the floor (3 × 10)
• Sitting heel raises (3 × 10)
• Eccentric heel raises standing on the floor (3 × 10)
Phase 2: Weeks 2–5
Patient status: Pain and difficulty with all activities, difficulty performing 10 single leg heel raises
Goal: Start to exercise, gain understanding of their injury and of pain monitoring model
Treatment program: Perform exercises every day:
• Pain monitoring model information and advice on exercise activity
• Circulation exercises (moving foot up and down)
• Double leg heel raises standing on the floor (3 × 10–15 repetitions)
• Single leg heel raises standing on the floor (3 × 10)
• Sitting heel raises (3 × 10)
• Eccentric heel raises standing on the floor (3 × 10)
Patient status: Pain with exercise, morning stiffness, pain when performing heel raises
Goal: Start strengthening
Treatment program: Perform exercises every day:
• Double leg heel raises standing on the edge of a step (3 × 15)
• Single leg heel raises standing on the edge of a step (3 × 10)
• Sitting heel raises (3 × 15)
• Eccentric heel raises standing on the edge of a step (3 × 15)
• Quick-rebounding heel raises (3 × 20)
Phase 3: Weeks 3–12 (longer if needed)
Patient status: Tolerates phase 2 exercise program well, no pain at distal portion of tendon, possibly increased or decreased morning stiffness
Goal: Heavier strength training, increase or begin running and/or jumping
Treatment program: Perform exercises every day with heavier load 2–3 times per week
• Single leg heel raises standing on the edge of a step with added weight (3 × 10)
• Sitting heel raises (3 × 15)
• Eccentric heel raises standing on the edge of a step with added weight (3 × 15)
• Quick-rebounding heel raises (3 × 20)
• Plyometric training
Phase 4: Weeks 12–6months (longer if needed)
Patient status: Minimal symptoms, morning stiffness but not every day, can participate in sports without difficulty
Goal: Heavier strength training, increase or begin running and/or jumping
Treatment program: Perform exercises every day with heavier load 2–3 times per week
• Single leg heel raises standing on the edge of a step with added weight (3 × 10)
• Eccentric heel raises standing on the edge of a step with added weight (3 × 15)
• Quick-rebounding heel raises (3 × 20)
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diverse timeframes for recovery. The Sports Surgery Clinic
(SSC) rehabilitation pathway [see Table 2] proposed in
this study involves 6 stages of progressive rehabilitation
(SSC6) from initial diagnosis and assessment, through de-
veloping strength, power and reactive strength, linear and
multi-directional running, and return to performance.
The existing literature has demonstrated positive clinical
outcomes using Silbernagel’s rehabilitation program [18,
44] and we have selected this a suitable comparative con-
trol for this study which involves a graded progression
pathway from combined concentric-eccentric exercises to
plyometric training [36].
Considering the multiple functional impairments expe-
rienced by athletes with AT, a battery of kinematic and
Fig. 1 Study design flow chart
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Pain > 5/10 on SL calf raise
Kinetic chain (2
days per week)
Box squat 3 × 8
reps @ 10RM
Step-up 3 × 8 reps
e/s @ 10RM
Calf Isometrics (daily)




Pain < 5/10 on SL calf raise
Kinetic chain (2
days per week)
Front squat 4 × 8
reps @ 10RM
Or
Deadlift 4 × 8 reps
@ 10RM
Step-up 3 × 8 e/s @
10RM
Or
Split squat 3 × 8
reps e/s
Calf strength (3 days per week)
SL calf raises 4 × 8 reps @ 10RM
~ Begin with dumbbell and shoes off
~ Aim to through 1st MTPJ and good
rearfoot control
Seated SL calf raises 4 × 10 reps @
12RM
~ Begin with kettlebell on knee and




Pain < 4/10 on SL calf raise
Kinetic chain (2
days per week)
Front squat 4 × 6
reps @ 8RM
Or
Deadlift 4 × 6 reps
@ 8RM
Step-up 3 × 6 e/s @
8RM
Or
Split squat 3 × 6
each side @ 8RM
Calf strength (3 times per week)
SL calf raises 4 × 8 reps @ 10RM
~ Progress to a smith machine or
barbell using rack for support
~ Aim for > 70% BW
Seated SL calf raises 4 × 10 reps @
12RM
~ Progress to smith machine or
landmine press
~ Aim for > 90% BW
Coordination/running
technique
Ankling 3 × 10m
March 3 × 10m




Pain < 5/10 for 10 DL hops




Front squat 4 × 6
reps @ 8RM
Or
Deadlift 4 × 6 reps
@ 8RM
Step-up 3 × 6 reps
e/s @ 8RM
Or
Split squat 3 × 6
each side @ 8RM
Calf strength (3 times per week)
SL calf raises 4 × 8 reps @ 10RM
~ Progress to a smith machine or
barbell using rack for support
~ Aim for > 80% BW
Seated SL calf raises 4 × 10 reps @
12RM
~ Progress to smith machine or
landmine press
~ Aim for > 110% BW
DL Reactive strength (2
times per week)
DL Pogo hops in-place 4 ×
10 (Day 1)
~ Keep knees straight and
stiff
~ Flat foot contacts
~ Active dorsiflexion during
flight phase
DL pogo hops forward 4 ×
10 (Day 2)
~ Keep knees straight and
stiff
~ Flat foot contacts





Pain < 4/10 for 10 SL hops
Exit criteria:
< 10% asymmetry in single leg
vertical and horizontal RSI
Kinetic chain (2
days per week)
Front squat 3 × 5
reps @ 7RM
Or
Deadlift 3 × 5 reps
@ 7RM
Step-up 3 × 5 reps
e/s @ 7RM
Or
Split squat 3 × 5
each side @ 7RM
Calf strength (3 times per week)
SL calf eccentric 4 × 8 reps @ 10RM
~ Use a smith machine/leg press/
barbell using rack for support
~ Up on 2 legs, lower down slowly
on 1 over 3 s
~ Aim for > 100% BW or equivalent
Seated SL calf raises 4 × 10 reps @
12RM
~ Progress to smith machine or
landmine press
~ Aim for > 110% BW
DL Reactive strength (2
times per week)
Drop jump 4 × 4 reps from
20 to 30 cm box
~ Maximum jump height
with minimal contact
~ Minimal knee bend on
ground contact
~ Cue “imagine the floor is
hot”
SL Reactive strength
(2 times per week)
SL pogo hops in-place
4 × 10 e/s (Day 1)
SL pogo hops forward







Front squat 3 × 5
reps @ 7RM
Or
Deadlift 3 × 5 reps
@ 7RM
Step-up 3 × 5 reps
e/s @ 7RM
Calf strength (2 times per week)
SL calf isometric 4 × 8 reps × 4 s
holds
~ Use a smith machine/leg press/
barbell using rack for support
~ Up on 2 legs, hold on 1
~ Aim for > 140% BW or equivalent
DL Reactive strength (2
times per week)
Drop jump 4 × 5 reps from
20 to 30 cm box
SL Reactive strength
(2 times per week)
SL pogo hops in-place
4 × 12 e/s (Day 1)
SL pogo hops forward
4 × 12 e/s (Day 2)
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kinetic tests to investigate plantar flexor strength, react-
ive strength and lower limb biomechanical variables in
hopping and running, may provide guidance on exercise
prescription, progression through a rehabilitation pro-
gram and return to sport decision-making. To the best
of our knowledge no study has assessed such breadth of
athletic qualities affected by AT.
This study will aim to compare the outcome of SSC6,
a multi-factorial, individualised criteria-based rehabilita-
tion program with Silbernagel’s combined concentric-
eccentric program, in physically active participants with
chronic mid-portion AT. In addition to the commonly
reported outcome measures of VISA-A, as secondary
outcome measures we will assess plantar flexor strength,
reactive strength and lower limb kinematic and kinetics
during running and hopping at 6-week intervals during
a 12-week rehabilitation program as these have not been
reported previously. We also further aim to investigate
the long term effects of rehabilitation programs and
achieved outcome measures over a 6, 12 and 24-month
follow-up period.
Aims
Using the VISA-A questionnaire as the primary outcome
measure, the aim of this study is to compare the effect-
iveness of Silbernagel’s daily exercise program with pro-
gression guided by pain symptoms, against SSC6’s
exercise program carried out 3 times per week with spe-
cific load targets. We will assess plantar flexor strength
using isokinetic dynamometry, reactive strength based
on a drop jump, and lower limb biomechanics during
a novel single leg horizontal rebound test and run-
ning, and investigate whether changes in these vari-
ables over the course of the 12-week rehabilitation
program are associated with improved pain and func-
tion outcomes using the VISA-A questionnaire when
comparing the two rehabilitation programs. We will
assess participant satisfaction with their prescribed
program, adherence and fidelity using a training diary
and perform follow-up interviews at 6, 12 and 24




This study will be a single-centre, parallel group
randomized-control trial. The data collection will take
place at the SSC Sports Medicine department at the
Sports Surgery Clinic in Dublin. The study protocol has
been reported using the Standard Protocol Items: Rec-
ommendations for Interventions (SPIRIT) statement
guidelines [Available in supplementary files]. The study
was approved by the Sports Surgery Clinic’s Research
Ethics Committee, (Application number: SAREB13/05/
19CG/MJ) and registered at ClinicalTrials.gov (ID:
NCT04384874).
Participants
Adult patients diagnosed with chronic mid-portion AT
who participate in running-based sports will be invited
to take part in this study. Patients who present to the
Sports Surgery Clinic (SSC) with Achilles pain will be
seen by a Sport and Exercise medicine physician, their
history and clinical examination will be confirmed with
magnetic resonance imaging (MRI). If the patient is di-
agnosed and meets the inclusion criteria, they will be in-
vited to participate in the study and will be given an
information sheet to read with a minimum of 24 h to
consider before agreeing by signing a consent form
[Additional file 2: Appendix 2]. Participants will also be
recruited externally through adverts on social media
channels, emails to coaching contacts and local sports
clubs. Participants who feel that they are eligible and
meet the inclusion criteria will be referred for examin-
ation by a sport and exercise medicine physician at the
clinic to confirm diagnosis and eligibility for the study.
Inclusion/exclusion criteria
Inclusion criteria
Participants will be eligible for this study if they are aged
18–45 years, perform running-based sports, are diag-
nosed with mid-portion AT, following a clinical examin-
ation by a sports medicine physician and confirmed with
MRI, and have been experiencing symptoms for more
than 3months but less than 3 years.




Pain > 5/10 on SL calf raise
Kinetic chain (2
days per week)
Box squat 3 × 8
reps @ 10RM
Step-up 3 × 8 reps
e/s @ 10RM
Calf Isometrics (daily)
5 × 45 s holds @ 60 s RM)
Or
Split squat 3 × 5
each side @ 7RM
Abbreviations: DL - double leg, SL - single leg, reps - repetitions, e/s - each side, BW - bodyweight, RM - repetition maximum
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Exclusion criteria
Patients will be ineligible for the study if they have a co-
existing lower-limb injury, have had a running-related
injury in the previous 12 months, or have had any peri-
tendinous, or intra tendinous Achilles injection in the
past 6 months, or previous Achilles surgery [15, 18, 44].
Randomisation and blinding
Participants will be assessed at baseline before being
randomly assigned to the intervention group or con-
trol group and will follow a prescribed rehabilitation
program for 12 weeks. See Table 3 for a summary of
the study design. The randomisation will be per-
formed using the online tool www.sealedenvelope.com
and the participant will be handed an envelope from
an independent observer not involved with the study,
containing their respective group allocation number.
The principal investigator and training group investi-
gators will be blinded to the group randomisation
process. These procedures have been used in similar
studies [45]. The participants will be prescribed with
an exercise program with video demonstrations of
each exercise under the supervision of the investigator
in their respective group. The program will be carried
out at home or in a local gym in addition to super-
vised rehabilitation sessions every 2–3 weeks at SSC.
Testing will take place again at week 6 and 12.
Follow-up interviews will take place at 6, 12 and 24
months after baseline testing. The investigator in-
volved with the testing and follow-up interviews will
also be blinded to the group allocation. The primary
outcome measure will be changes to the VISA-A
questionnaire. Secondary outcome measures will in-
clude plantar flexor strength, lower limb reactive
strength, biomechanics and running gait.
Outcome measures and assessments
Investigations
At baseline, week 6 and 12, all participants will be re-
quired to complete a VISA-A questionnaire as well as per-
form isokinetic testing and 3D motion capture running
gait assessment. In addition, hop testing will be performed
at week 6 and 12 [see Table 3]. Hop testing is included in
the testing battery from week 6 onwards as it is expected
some participants with Achilles pain at baseline testing
may be fearful of performing hopping tasks or risk of ex-
acerbating their pain, and the data collected may not be
an accurate reflection of their capabilities.
Primary outcome measure
VISA-A questionnaire
The VISA-A questionnaire has been shown to be a valid,
reliable and easy-to-use outcome measure tool for inter-
vention studies on AT [46]. It consists of eight questions
regarding pain and function during both daily living and
sporting activities. The overall score is between 0 and
100 where higher scores represent reduced pain and im-
proved function. An improvement of 21 points between
2 and 12 weeks of a rehabilitation program have been
typically observed [44]. While the VISA-A score will not
determine eligibility for inclusion into the study, it will
be used to map progress over the course of the rehabili-
tation program and in the follow-up period. The differ-
ence in VISA-A score between both training protocols
from baseline testing to the outcome testing at 6 weeks,
12 weeks, 3, 6 and 12 months; will formulate the primary
outcome measure for this study.
Secondary outcome measures
Isokinetic plantar flexor strength
Reduced plantar flexor strength is a common feature in
patients with Achilles tendinopathy [14–16, 39]. One
Table 3 Overview of outcome measures over the course of the study
Baseline Week 6 Week 12 6months 12months 24months
Body mass X
Body height X
Body mass index X
Sport/activity level X X X XX
VISA-A Questionnaire X X X X X X
Isokinetic plantar flexor peak torque (knee extension) X X X
Isokinetic plantar flexor peak torque (knee flexion) X X X
3D running gait analysis X X X
Double leg drop jump X X
Single leg drop jump X X
Single leg horizontal rebound X X
Exercise compliance X X X
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prospective study to date established that plantar flexor
torque below 50 Nm was a risk factor for developing AT
[47]. Isokinetic testing is commonly used to measure
plantar flexor peak torque [15, 16, 39].
Two separate protocols will be used for this test. In
the first protocol, the participant will lie prone with full
knee extension. In the second protocol, the participant
will lie supine with 80° knee flexion. When the knee is
flexed to greater than 60°, the force contribution of the
biarticular gastrocnemius muscles to plantarflexion is re-
duced, and is thus representative of the force produced
predominantly by soleus muscle [48]. If similar plantar
flexor peak torque deficits exist between the two proto-
cols, the identified deficits may thus be attributed to the
soleus muscle [15] which will influence exercise
prescription.
The testing will be performed on a isokinetic dyna-
mometer (Cybex Norm, Computer Sports Medicine
Inc.). In both protocols, the participant will have their
foot strapped to a pedal with the centre of axis of rota-
tion aligned with the medial malleolus and a correction
for gravity applied. Beginning with their uninjured limb,
participants will be asked to perform a warm-up involv-
ing 5 sub maximal concentric plantarflexion and dorsi-
flexion contractions increasing progressively from 60 to
100% of their self-perceived MVC for familiarisation.
The participants will then be required to produce a max-
imal plantarflexion force over 5 repetitions for 2 sets
with a 1 min rest between sets. Verbal encouragement
will be provided to produce maximal effort through full
range of motion for each repetition. In the second test,
the participants will lie in supine position with the knee
flexed to 80° in order to specifically test the peak torque
of the soleus. The same familiarisation protocol, sets and
repetitions as the previous test will apply. Both tests will
use an angular velocity of 60° per second and operate
through an ankle range of between 30° plantarflexion
and 20° dorsiflexion. Data will be sampled at 100 and
peak torque expressed as percentage of body mass (Nm/
kg %) will be reported on both limbs. Between-limb
asymmetries in peak torque will also reported and
analysed.
Three-dimensional running gait analysis
Altered running biomechanics and muscle recruitment
strategies have been highlighted in runners with AT
[49–52]. Using a proprietary three-dimensional optical
motion analysis system (Run 3D, Oxford, United King-
dom) the following kinematic and spatiotemporal vari-
ables will be measured: contact time, aerial time, stride
length, stride frequency and joint angular displacements
from initial contact to mid stance phase. Lower limb
stiffness will be calculated using a validated equation
based on the spring-mass model with running speed,
contact time, body mass and leg length as inputs [53].
The participants will warm-up by running for between 2
and 5min on the treadmill at a self-selected speed. Once
they report that they are adequately warmed up they will
be instructed to run at a speed that they feel they would
be comfortable running at a steady pace for 30 min. Data
will be captured for 30 s at a random interval over a 2
min period and the participants will not be informed
about when the data capture begins. For the subsequent
tests at week 6 and 12, the participants will be required
to repeat the same speed for re-analysis.
Hop tests
Achilles tendon material properties contribute to stretch
shortening cycle performance during hopping and jump-
ing exercises [54, 55]. Reduced tendon mechanical prop-
erties, plantar flexor muscle rate of force development
and deficits on a single forward hop test have previously
been observed in patients with AT [23].
The hop tests will take place on two force platforms
(AMTI, USA) to measure ground reaction force (GRF)
data sampled at 1000 Hz. Ten infrared cameras (200 Hz;
Bonita B10/Vero v2.2, Vicon, UK) will be used for three-
dimensional motion capture. Reflective markers (14 mm
diameter) placed on all relevant anatomical landmarks
including the thorax, will be used in accordance with a
modified Plug-in-gait model (Vicon, UK) [56], with
centre of mass (COM) calculated from all segments.
Motion and force data will be filtered using a fourth
order zero-lag low pass Butterworth filter with a cut-off
frequency of 15 Hz. The data will be exported to
MATLAB 2015a (Mathworks, USA) for processing. Par-
ticipants will perform 3 trials on each test, unshod and
with hands placed on iliac crests.
Drop jump Participants will perform both a double leg
drop jump (DLDJ) and single leg drop jumps (SLDJ).
The participants will complete a standardised warm-up
which consists of 10 bodyweight squats, followed by 10
pogo hops in place and 3 familiarisation trials for both.
A 30 cm box will be used for the DLDJ and a 20 cm box
for the SLDJ. The participant who will be unshod with
hands placed on iliac crests, will be required to drop off
the box and rebound off the force plate as quickly as
possible aiming for maximum jump height. They will be
instructed to maintain knee and hip extension during
flight phase and where there is visible evidence of knee
flexion or a ‘tuck jump’, the trial will be deemed invalid
and they will be asked to repeat until a competent trial
is achieved. The ground contact phase will be defined by
a GRF greater than 20 N and jump height will be calcu-
lated from centre of mass displacement using kinematic
data. Reactive strength index (RSI), which is a measure
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of jump height divided by ground contact time, will be
calculated for both the double and single leg drop jump.
Single leg hurdle hop After completing the drop jump
tests, participants will be asked to perform a single leg
forward hurdle hop test (SLHH). The test requires that
participants to perform a single leg forward hop over
two 15 cm hurdles rebounding off the force platform in
between, completing 3 trials on each leg. The partici-
pants will be instructed to rebound ‘as fast as possible’
and ‘as far as possible’, and to attempt to be fully stable
on 1 leg upon landing. After each trial the participants
will walk back slowly to begin the next trial taking ap-
proximately 10 s recovery time. Hop distance, rebound
distance and contact time, as well as key biomechanical
variables such as vertical, horizontal and leg ground re-
action force, vertical, leg and joint stiffness, joint powers
and moments, and joint angular displacements will be
calculated using a custom MATLAB script (Mathworks,
USA). Hop distance will be calculated as the distance
from the initiation of the hop to the initial contact as
the participants lands at the end of the hop and rebound
distance from the force plate to the landing. Vertical
stiffness (Kvert) will be calculated at the point of max-
imum displacement of COM, as the ratio of change in
vertical ground reaction force (GRF) to COM
displacement:
Kvert ¼ ΔForce=ΔCoM
Leg stiffness will be calculated in the sagittal plane as
the ratio of change in leg ground reaction force (Fleg) to
the change in leg length at the shortest leg length during
stance phase as previously proposed [57]. Leg length is
measured as the distance from the hip joint centre to
the centre of pressure in the sagittal plane, while Fleg is
calculated from the resultant GRF magnitude scaled to
the leg angle using the trigonometry sine rule.
Kleg ¼ ΔFleg=ΔLeg
Joint stiffness (Kankle, Kknee and Khip) at the ankle and
knee, will be calculated in the sagittal plane as the ratio
of change in joint moment to change in joint
displacement:
Kjoint ¼ Δ moment=Δ angle
A pilot study has previously been carried out on 10
healthy participants prior to the commencement of the
Achilles RCT study [58]. Good-to-excellent reliability
(ICC > 0.75) was found for hop and rebound distance,
contact time, knee and ankle joint stiffness, vertical and
leg GRF, with moderate reliability (ICC 0.50–0.75) for
reactive strength index, vertical and leg stiffness, ankle
joint peak power, ankle and knee joint peak moments,
and horizontal GRF. In a separate study using the same
protocol, 3 trials were sufficient to obtain a stable meas-
ure of performance across key variables [59].
Training diary
In order to determine adherence and fidelity with the re-
habilitation program and pain response to exercise, each
patient will be required to complete a training diary log-
ging their completed running and rehabilitation sessions
as well as reporting any pain symptoms using a numer-
ical pain rating scale (NPRS), that will be reviewed at
week 6 and returned at week 12. Adherence is defined
as the proportion of prescribed exercises completed
while fidelity refers to whether the participant completed
the prescribed exercises, sets, repetitions and target
loads. Participants will be advised to take an extra recov-
ery day between exercise sessions if pain was above 5/10
on the day after a session and to adjust their loads for
the subsequent session.
Follow-up interviews
At 6, 12 and 24 months from baseline testing, patients
will be required to complete a questionnaire [see Add-
itional file 1: Appendix 1] to analyse their participation
in their respective sport, document any re-injuries and
to obtain patient satisfaction feedback on their respective
rehabilitation program. These outcomes will be reported
and compared between groups to determine if the re-
habilitation program had any significant effect (Fig. 1).
Interventions
Each participant will be prescribed a graded rehabilita-
tion exercise training program which they will perform
at home or in a local gym. However, they will present
themselves for one supervised session every 2–3 weeks
by their respective group investigators to ensure compli-
ance and appropriate progression. The patients following
Silbernagel’s training program [see Table 1] will perform
solely calf strength exercises with self-prescribed add-
itional resistance and will progress their exercises based
on a NPRS, where there is no greater than a 4/10 pain
response during and in the 24 h following a training ses-
sion. They will then progress to plyometric exercises as
tolerated. The SSC6 group [see Table 2] will follow a
multifactorial exercise program comprising of bilateral
and unilateral kinetic chain strength, calf strength and
plyometric training as well as running drills as early as
they can tolerate them. The participants will enter at the
highest level where they meet the minimum criteria. For
the calf exercises, they will be encouraged to lift a cer-
tain percentage of bodyweight in additional resistance
and increase weekly. A certain level of pain within toler-
able limits will be accepted and participants will be en-
couraged to increase their resistance loading weekly so
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long as that pain doesn’t increase. Progression to Level 4
of the program will be based on achieving their pre-
scribed exercise load targets and achieving a deficit of
less than 10% between injured and uninjured limbs on
the isokinetic strength tests. The reactive strength exer-
cises will be performed at near maximal intensity for a
set number of repetitions with good competency and
within tolerable pain limits. The participants will pro-
gress to Level 5 when they can perform 10 single leg
hops with a score of < 4/10 on the NPRS and progress
from Level 5 when single leg RSI deficits are < 10%. Out-
come measures will be monitored at the various time-
points and will be tracked according to reported NPRS
ratings. In both groups, participants will be permitted to
begin running in phase 2 when pain during daily activity
is < 2/10 but will be advised on periodising their running
and rehabilitation exercises throughout the week. Each
participant will be provided with a training log in order
to monitor training loads. Should an adverse event occur
which results in re-injury or a new injury, the participant
will be instructed to contact their respective investigator
immediately so that they can be examined and their
treatment will be adjusted, postponed or discontinued
where appropriate. Upon completion of the training
intervention, participants in both groups will be given a
maintenance training program for 6 months. The design,
prescription and reporting of the training intervention
meets all of the 16-item checklist requirements in the
Consensus on Exercise Reporting Template (CERT) [60]
[Available in supplementary files].
See Tables 1 and 2 for an example of the exercise pro-
grams, and Table 4 for the points of difference between
to two training interventions.
Statistical analysis and power calculation
This study is powered to detect a change of 15 points on
the VISA-A questionnaire, similar to previous studies in-
vestigating clinical changes after a rehabilitation pro-
gram [61, 62]. The average reported change in a VISA-A
questionnaire after a 12-week intervention is 21 points
with a standard deviation 6.6 points [44]. Assuming a
power of 80% and a two-sided 5% significance level, a
total of 25 participants in each group would be required.
Allowing for a conservative drop-out rate of 15%, the
proposed total sample size is 60, with 30 in each group.
This number is similar to those used in other high qual-
ity injury rehabilitation RCT studies [40, 45].
Statistical analysis will be performed using R (R Studio
version 1.2.5). Descriptive statistics will be used for all
continuous variables, and means and standard deviations
will be reported. Comparisons between both groups at
different timepoints will be assessed using Student’s in-
dependent samples two-tailed t-tests. An intention to
treat analysis will be used to test a within-group and
between-group change in VISA-A questionnaire score at
testing and follow-up timepoints, using a repeated mea-
sures Analysis of Covariance (ANCOVA). The primary
outcome measure - changes to the VISA-A question-
naire, will the dependent variable, group will the be-
tween participants factor and time will be the covariate.
Table 4 SSC6 Versus Silbernagel’s rehabilitation program.
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Non-parametric equivalents (Matt-Whitney U-Test and
Friedman Test respectively) will be used if a Shapiro-
Wilk test indicates that the assumption of normality has
not been met. A multiple regression analysis will be used
to investigate the total variance and the relative weight
of each independent variable with changes in VISA-A
score as the dependent variable. The independent vari-
ables will be changes in plantar flexor strength, reactive
strength and lower limb biomechanical variables, as well
as exercise adherence and fidelity. Effect sizes will be re-
ported using partial eta squared threshold values of > 0.2
(small), > 0.5 (moderate), and > 0.8 (large). Statistical sig-
nificance will be accepted at α = 0.05.
Discussion
Exercise therapy is widely accepted as the primary treat-
ment option for runners with AT [35, 36, 63]. Heavy re-
sistance strength exercises targeting the muscle-tendon
unit have been shown to increase physiological cross-
sectional area and pennation angle in the muscle [64]
and tendon mechanical and material properties [41, 65].
This type of loading has resulted in improved clinical
outcomes in AT patients [40, 44]. Plyometric training
prepares the muscle tendon unit for high tensile forces
and loading rates associated with running based sports
[2, 36, 66]. However, there is no clear guidance on how
to prescribe and progress the loading for calf strength
exercises apart from using pain response to exercise.
Only a few studies have investigated running biomech-
anical features associated with AT with limited evidence
for poor control of rearfoot eversion [50, 67] and re-
duced leg stiffness on the injured limb [24].
An acceptable level of pain symptoms are permitted
during AT rehabilitation [18, 34] and it remains to be
explored if a primary focus on achieving strength, react-
ive strength and biomechanical targets can lead to simi-
lar outcomes in reduced timeframes and with lower re-
injury rates. This is the first study to propose an indivi-
dualised, criteria-based graded rehabilitation program in
patients in with chronic mid-portion Achilles tendinopa-
thy where progression is guided by strength and reactive
strength outcome measures within tolerable pain limits.
The participants in our study will undertake a compre-
hensive assessment of kinematic and kinetic tests to in-
vestigate plantar flexor strength, reactive strength and
lower limb biomechanical variables in hopping and run-
ning. We will perform long term evaluations at evalua-
tions at 6, 12 and 24 months to monitor progress, re-
injury incidences and sustainability of return to sport
and investigate patient satisfaction with their respective
rehabilitation exercise programs.
Our study will include a sample of participants who
practise running-based sports and are of a particular age
profile (age 18–45), have had no injection therapies in
the previous 6 months and no co-existing lower limb in-
juries. Like most studies of similar design, there is a high
risk of drop-outs, poor compliance with the respective
programs and failure to respond to the follow-up ques-
tionnaires. This will be managed by aiming for a higher
number of participants than the study is powered for
and maintaining regular communication with the
participants.
In summary, this two-arm RCT will compare the ef-
fectiveness of a criteria-based rehabilitation program
with progression guided by achieving functional out-
come measures with an evidenced-based program where
progression is guided solely by pain symptoms. The re-
sults of this study will provide insights as to whether im-
proved strength, reactive strength and lower limb
biomechanics are associated with reduced pain in pa-
tients with chronic mid-portion AT and assist clinicians
treating this injury to set objective criteria to progress
rehabilitation and return to sport.
Trial status
Recruitment for the trial started in January 2020 and it
is anticipated that data collection will be completed in
April 2023. As of November 9th 2020, 18 participants
have been included.
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